Annual CFI
-$12.25 M
+$18.22 M+59.81%
December 31, 2024
Summary
- As of March 7, 2025, IBRX annual cash flow from investing activities is -$12.25 million, with the most recent change of +$18.22 million (+59.81%) on December 31, 2024.
- During the last 3 years, IBRX annual CFI has risen by +$72.64 million (+85.57%).
- IBRX annual CFI is now -144.86% below its all-time high of $27.30 million, reached on December 31, 2022.
Performance
IBRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$9.83 M
-$55.20 M-84.88%
December 31, 2024
Summary
- As of March 7, 2025, IBRX quarterly cash flow from investing activities is $9.83 million, with the most recent change of -$55.20 million (-84.88%) on December 31, 2024.
- Over the past year, IBRX quarterly CFI has dropped by -$55.20 million (-84.88%).
- IBRX quarterly CFI is now -91.57% below its all-time high of $116.67 million, reached on June 30, 2022.
Performance
IBRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$12.25 M
+$7.58 M+38.25%
December 31, 2024
Summary
- As of March 7, 2025, IBRX TTM cash flow from investing activities is -$12.25 million, with the most recent change of +$7.58 million (+38.25%) on December 31, 2024.
- Over the past year, IBRX TTM CFI has increased by +$7.58 million (+38.25%).
- IBRX TTM CFI is now -113.90% below its all-time high of $88.13 million, reached on March 31, 2023.
Performance
IBRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
IBRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.8% | -84.9% | +38.3% |
| 3 y3 years | +85.6% | -84.9% | +38.3% |
| 5 y5 years | -166.0% | -84.9% | +38.3% |
IBRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -144.9% | +85.6% | -91.6% | +107.1% | -113.9% | +93.4% |
| 5 y | 5-year | -144.9% | +85.6% | -91.6% | +107.1% | -113.9% | +93.4% |
| alltime | all time | -144.9% | +85.6% | -91.6% | +107.1% | -113.9% | +93.4% |
ImmunityBio Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$12.25 M(-59.8%) | $9.83 M(-84.9%) | -$12.25 M(-38.2%) |
| Sep 2024 | - | $65.03 M(-226.3%) | -$19.83 M(-80.3%) |
| Jun 2024 | - | -$51.49 M(+44.5%) | -$100.49 M(+74.4%) |
| Mar 2024 | - | -$35.62 M(-1683.9%) | -$57.61 M(+89.1%) |
| Dec 2023 | -$30.47 M(-211.6%) | $2.25 M(-114.4%) | -$30.47 M(-41.0%) |
| Sep 2023 | - | -$15.63 M(+81.7%) | -$51.61 M(+38.9%) |
| Jun 2023 | - | -$8.60 M(+1.4%) | -$37.15 M(-142.2%) |
| Mar 2023 | - | -$8.48 M(-55.1%) | $88.13 M(+222.8%) |
| Dec 2022 | $27.30 M | -$18.89 M(+1517.6%) | $27.30 M(-129.8%) |
| Sep 2022 | - | -$1.17 M(-101.0%) | -$91.61 M(+14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $116.67 M(-268.3%) | -$79.86 M(-57.1%) |
| Mar 2022 | - | -$69.31 M(-49.7%) | -$186.04 M(+119.2%) |
| Dec 2021 | -$84.89 M(+328.5%) | -$137.80 M(-1402.2%) | -$84.89 M(-240.4%) |
| Sep 2021 | - | $10.58 M(+0.9%) | $60.46 M(-996.2%) |
| Jun 2021 | - | $10.49 M(-67.1%) | -$6.75 M(+244.0%) |
| Mar 2021 | - | $31.84 M(+322.1%) | -$1.96 M(-90.1%) |
| Dec 2020 | -$19.81 M(-206.8%) | $7.54 M(-113.3%) | -$19.81 M(-27.6%) |
| Sep 2020 | - | -$56.63 M(-470.7%) | -$27.36 M(-193.5%) |
| Jun 2020 | - | $15.27 M(+9.1%) | $29.27 M(+109.1%) |
| Mar 2020 | - | $13.99 M | $13.99 M |
| Dec 2019 | $18.55 M | - | - |
FAQ
- What is ImmunityBio annual cash flow from investing activities?
- What is the all time high annual CFI for ImmunityBio?
- What is ImmunityBio annual CFI year-on-year change?
- What is ImmunityBio quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ImmunityBio?
- What is ImmunityBio quarterly CFI year-on-year change?
- What is ImmunityBio TTM cash flow from investing activities?
- What is the all time high TTM CFI for ImmunityBio?
- What is ImmunityBio TTM CFI year-on-year change?
What is ImmunityBio annual cash flow from investing activities?
The current annual CFI of IBRX is -$12.25 M
What is the all time high annual CFI for ImmunityBio?
ImmunityBio all-time high annual cash flow from investing activities is $27.30 M
What is ImmunityBio annual CFI year-on-year change?
Over the past year, IBRX annual cash flow from investing activities has changed by +$18.22 M (+59.81%)
What is ImmunityBio quarterly cash flow from investing activities?
The current quarterly CFI of IBRX is $9.83 M
What is the all time high quarterly CFI for ImmunityBio?
ImmunityBio all-time high quarterly cash flow from investing activities is $116.67 M
What is ImmunityBio quarterly CFI year-on-year change?
Over the past year, IBRX quarterly cash flow from investing activities has changed by -$55.20 M (-84.88%)
What is ImmunityBio TTM cash flow from investing activities?
The current TTM CFI of IBRX is -$12.25 M
What is the all time high TTM CFI for ImmunityBio?
ImmunityBio all-time high TTM cash flow from investing activities is $88.13 M
What is ImmunityBio TTM CFI year-on-year change?
Over the past year, IBRX TTM cash flow from investing activities has changed by +$7.58 M (+38.25%)